Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

<< Previous

Bullboard Posts

Next >>

Post by Ticklel1ston Oct 16, 2021 3:52pm

177 Views

Post# 34013818

Pool on Management

How about we all chip in 10,000 shares and have a pool on management being able to meet ther own expectations before the AGM.

Howhee. You just bought on the open market. Are you putting 10K share you are going to meet you goals pre agm or not? LOLs

To tell the truth. I would like him to hold a virtual meeting and open the floor to questions from sharheolders.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management